European Journal of Surgical Oncology
Volume 34, Issue 3 , Pages 333-338 , March 2008

Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection

  • G.-Y. Chau

      Affiliations

    • Department of Surgery, Division of General Surgery, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, No. 201, Shih-pai Road, Section 2, Shih-pai, Taipei 112, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886 2 2875 7652; fax: +886 2 2875 7537.
  • ,
  • W.-Y. Lui

      Affiliations

    • Department of Surgery, Division of General Surgery, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, No. 201, Shih-pai Road, Section 2, Shih-pai, Taipei 112, Taiwan
  • ,
  • C.-W. Chi

      Affiliations

    • Department of Medical Research and Education, Taipei Veterans General Hospital; Institute of Pharmacology, School of Medicine, National Yang-Ming University, No. 201, Shih-pai Road, Section 2, Shih-pai, Taipei 112, Taiwan
  • ,
  • Y.-P. Chau

      Affiliations

    • Institute of Anatomy and Cell Biology, School of Medicine, National Yang-Ming University, No. 155, Li-Nong Street, Section 2, Peitou, Taipei 112, Taiwan
  • ,
  • A.-F. Li

      Affiliations

    • Department of Pathology, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, No. 201, Shih-pai Road, Section 2, Shih-pai, Taipei 112, Taiwan
  • ,
  • H.-L. Kao

      Affiliations

    • Department of Surgery, Division of General Surgery, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, No. 201, Shih-pai Road, Section 2, Shih-pai, Taipei 112, Taiwan
  • ,
  • C.-W. Wu

      Affiliations

    • Department of Surgery, Division of General Surgery, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, No. 201, Shih-pai Road, Section 2, Shih-pai, Taipei 112, Taiwan

,Accepted 5 December 2006.

References 

  1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750
  2. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and non-surgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000;32:1224–1229
  3. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Long-term results of hepatic resection for hepatocellular carcinoma originating from the non-cirrhotic liver. Arch Surg. 2004;139:320–325
  4. Poon RTP, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24
  5. Chau GY, Lui WY, Wu CW. Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:25–34
  6. Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest. 1988;81:414–419
  7. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 1992;182:802–809
  8. Noji S, Tashiro K, Koyama E, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun. 1990;173:42–47
  9. Matsumoto K, Nakamura T. Hepatocyte growth factors: molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol. 1991;6:509–519
  10. Ljubimova JY, Petrovic LM, Wilson SE, Geller SA, Demetriou AA. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. J Histochem Cytochem. 1997;45:79–87
  11. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver disease: clinical implication. Hepatology. 1995;21:106–112
  12. Matsumoto K, Nakamura T, Kramer RH. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem. 1994;269:31807–31813
  13. Neaud V, Faouzi S, Guirouilh J, et al. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Hepatology. 1997;26:1458–1466
  14. Monvoisin A, Neaud V, De Ledinghen V, et al. Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase. J Hepatol. 1999;30:511–518
  15. Junbo H, Li Q, Zaide W, Yunde H. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis. In Vivo. 1999;13:177–180
  16. Yamazaki H, Oi H, Matsumoto K, et al. Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepatocellular carcinoma. Cytokine. 1996;8:178–182
  17. Wu F, Wu L, Zheng S, et al. The clinical value of hepatocyte growth factor and its receptor-c-met for liver cancer patients with hepatectomy. Dig Liver Dis. 2006;38:490–497
  18. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 1991;13:743–749
  19. Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomized and non-hepatectomized surgical patients. Gastroenterology. 1992;103:1621–1624
  20. Selden C, Johnstone R, Darby H, Gupta S, Hodgson HJ. Human serum does contain a high molecular weight hepatocyte growth factor: studies pre-and post-hepatic resection. Biochem Biophys Res Commun. 1986;139:361–366
  21. Higaki I, Yamazaki O, Matsuyama M, et al. Portal serum human hepatocyte growth factor levels after partial hepatectomy. Hepatogastroenterology. 1999;46:1078–1082
  22. Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery. 2000;127:603–608
  23. Tsubouchi H. Hepatocyte growth factor for liver disease. Hepatology. 1999;30:333–334
  24. Selden C, Farnaud S, Ding SF, Habib N, Foster C, Hodgson HJ. Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumors. J Hepatol. 1994;21:227–234
  25. In:  Greene FL,  Page DL,  Fleming ID, et al. editor. Liver including intrahepatic bile ducts. In: American Joint Committee on Cancer Staging Manual. 6th ed.. New York: Springer; 2002;p. 131–144
  26. Yamagamim H, Moriyama M, Matsumura H, et al. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Cancer. 2002;95:824–834
  27. Noguchi O, Enomoto N, Ikeda T, Kobayashi F, Marumo F, Sato C. Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma. J Hepatol. 1996;24:286–292
  28. Nagata K, Hirono S, Ido A, et al. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2001;289:205–211
  29. De Ledinghen V, Monvoisin A, Neaud V, et al. Trans-resveratrol, a grapevine-derived polyphenol, blocks hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells. Int J Oncol. 2001;19:83–88
  30. Heideman DA, Overmeer RM, van Beusechem VW, et al. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy. Cancer Gene Ther. 2005;12:954–962

PII: S0748-7983(06)00492-6

doi: 10.1016/j.ejso.2006.12.007

European Journal of Surgical Oncology
Volume 34, Issue 3 , Pages 333-338 , March 2008